In addition, the strong commitment and support of our shareholder Astorg demonstrates their strategic vision for CordenPharma to become the leading CDMO for complex modalities such as Peptides, by offering fully-integrated end-to-end services from APIs to Drug Products (for both Injectable and Oral Peptides). Dr
Summer and I discuss: What food noise is, and how it goes far beyond hunger or cravings Her personal experience with obesity, weight loss, and taking GLP-1s Overlap between food noise, chronic dieting, and disordered eating patterns Who should (and shouldn't) be on these drugs Risks and benefits of GLP-1 use in different populations The importance of ongoing professional support while using GLP-1 meds Why inappropriate GLP-1 use cases shouldnt overshadow people genuinely benefiting from these medications How weight stigma and judgment can make conversations around GLP-1 use even more difficult Why compassion, individualized care, and ongoing professional support matter I hope this episode helps you better understand GLP-1 medications and the experiences of those who use them
Safer for Certain Medical Conditions: Additionally, its lack of reliance on the vascular system allows it to be effective even in populations with conditions like diabetes or cardiovascular disease, where blood flow might be compromised
Innovations in hardware, nanoparticle engineering, and the integration of real-time imaging and artificial intelligence will enhance the precision and effectiveness of these therapies
